The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026. Increasing awareness among consumers regarding the advantages of cosmeceuticals over ordinary cosmetics will lead to a wider product adoption. According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectables and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion in 2018 and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521

The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions. E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy. Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/e-prescribing-market-102698

The global medical lasers market will witness considerable growth due to growing applications of medical lasers in surgical procedures. According to a report published by Fortune Business Insights, titled “Medical Lasers: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,778.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 12,327.8 Mn by 2026, thereby exhibiting a CAGR of 15.9%. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/medical-lasers-market-101071

The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026. visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600

The global pressure ulcer (PU) treatment market is expected to gain momentum from the rising adoption of innovative wound care devices for treatment. As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually. It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/pressure-ulcer-treatment-market-102095 This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period. However, it stood at USD 6.69 billion in 2018.

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027. Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027. For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656

The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market. Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period. North America is expected to contribute significantly towards the growth of the revenue cycle management market. Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019. It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period. For More Questions, Talk with Respiratory Syncytial Virus (RSV) Therapeutics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/respiratory-syncytial-virus-rsv-therapeutics-market-104668